Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
SUNRISE, FL – April 24, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced…
USRM Announces 2017 Financial Results
SUNRISE, FL – April 16, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
Newest Clinic Opens Today at The Villages in Central Florida
SUNRISE, FL – April 9, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced…
USRM Chief Science Officer to Present at Paleo f(x) Ancestral Healing Conference in Austin, Texas
SUNRISE, FL – March 20, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, is…
USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference
SUNRISE, FL – February 28, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announces…
USRM Posts Live Webinar with World Renowned Biohacker
‘Enhancing Sexual Performance with Stem Cell Therapy’ Available for Playback SUNRISE, FL – Feb. 20, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary,…
CEO Blog: February 2018
Dear Shareholders and Friends, Thank you all so much for taking the time to learn more about our recent progress. In this post, we want to take a moment to…
USRM CSO to Host Live Stem Cell Info Webinar with World Renowned Biohacker
‘Discussing Enhancing Sexual Performance with Stem Cell Therapy’ Feb. 17 at Noon SUNRISE, FL – Feb. 14, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development…
USRM Successfully Launches Stem Cell Webinar Series
Open to Global Participation, More than 100 Attendees in First Q & A SUNRISE, FL – Feb. 12, 2018 – Dr. Kristin Comella, Chief Science Officer of U.S. Stem Cell,…
USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
Failure of Opioids & Economic Growth Driving Force, CSO to Host Live Info Webinar SUNRISE, FL – Feb. 6, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in…
USRM Chief Science Officer Featured in Powerful Stem Cell Docuseries
SUNRISE, FL – Jan. 24, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Reaches Key Sales Milestone of Proprietary Adipocell TM Product
Company Poised to Be Industry Leader in Autologous Adipose Stem Cell Treatments SUNRISE, FL – Jan. 15, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development…